title: Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes? [Letter to the Editor].
authors.affiliation: Department of Endocrinology and Nutrition, University Hospital of Castellón, Castellón de la Plana, Spain.
authors.forename: Agustín Ángel
authors.initials: AÁ
authors.lastname: Merchante-Alfaro
authors.forename: Susana
authors.initials: S
authors.lastname: Pérez-Naranjo
authors.forename: Pablo
authors.initials: P
authors.lastname: Abellán-Galiana
authors.forename: Olalla
authors.initials: O
authors.lastname: Rubio-Puchol
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D015331:Cohort Studies; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D049528:Insulin, Long-Acting / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013030:Spain / Q000453:epidemiology; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; C571886:insulin degludec